ANRO stock news
This page provides real-time market news, earnings updates, and company announcements related to Alto Neuroscience, Inc. (ANRO).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-15 14:07 EST
Why CrowdStrike (CRWD) Stock Is Plummeting Today
101 finance2026-02-05 20:48:37
Upwork: Fourth Quarter Financial Overview
101 finance2026-02-09 21:24:14
AI disruption fears create buying chance in US software stocks, strategists say
101 finance2026-02-10 17:45:29
No, Artificial Intelligence Isn’t Destroying Software: OKTA and Other Leading Stocks to Revive After the ‘SaaS-pocalypse’
101 finance2026-02-11 03:00:37
JPMorgan lowers Palo Alto Networks target price to $225
格隆汇2026-02-11 08:26:22
How Are Investors Responding to Current AI Concerns? ‘Sell Now, Worry About the Details Later’
101 finance2026-02-11 20:30:59
AppLovin: Q4 Financial Highlights
101 finance2026-02-11 21:30:35
BridgeBio Reports Positive Phase 3 Topline Results for Oral Infigratinib with the First Statistically Significant Improvements in Body Proportionality in Achondroplasia
Finviz2026-02-12 12:36:09
Palo Alto plans dual listing in Tel Aviv after closing $25 billion CyberArk deal
101 finance2026-02-12 15:03:33
Datadog Inc.'s (DDOG) Strong Q4 Reinforces AI Observability Position Amid Competition
Finviz2026-02-12 15:39:39
Cybersecurity Stock in the Spotlight Ahead of Earnings
Finviz2026-02-12 20:39:31
Palo Alto Networks (PANW) Falls More Steeply Than Broader Market: What Investors Need to Know
Finviz2026-02-12 23:48:06
JPMorgan Flags 'AI-Resilient' Software Names After Selloff
Finviz2026-02-13 12:27:43
Alto Neuroscience (stock code: ANRO) has successfully completed patient enrollment for its Phase II proof-of-concept study of the candidate drug Alto-101 for cognitive impairment associated with schizophrenia.
老虎证券2026-02-13 13:28:26
Broadcom Inc. (AVGO) Draws ARK Investment Amid Positive AI Growth Outlook
Finviz2026-02-13 15:12:48
Palo Alto Networks to Report Q2 Earnings: How to Play the Stock
Finviz2026-02-13 16:36:37
Stocks End Modestly Up as Bond Yields Decline
101 finance2026-02-14 00:48:13
Previewing Retail Sector Earnings: A Closer Look
Finviz2026-02-14 00:51:38
Goldman Sachs launches "AI-Resistant" U.S. Stock Investment Portfolio
美股投资网2026-02-14 02:41:03
Cybersecurity Demand Is High-Yet This ETF Is on Sale
Finviz2026-02-14 14:03:42
CrowdStrike (CRWD) Draws Fresh Optimism as HSBC Sees Attractive Entry Point
Finviz2026-02-14 14:24:08
From warnings of a "slippery slope" to describing it as an "existential threat," automotive industry leaders are raising concerns about competition from China
101 finance2026-02-14 15:33:13
What’s Ahead in the Markets This Week: Walmart Reports; Updates on Inflation, Housing, and Trade; Fourth Quarter GDP; and Presidents Day Observance
101 finance2026-02-15 11:03:39
Walmart's financial results, consumer spending trends, and further AI developments: Key highlights to follow this week
101 finance2026-02-15 13:00:40
JPMorgan lowers Palo Alto Networks target price to $225
格隆汇2026-02-11 08:26:22
How Are Investors Responding to Current AI Concerns? ‘Sell Now, Worry About the Details Later’
101 finance2026-02-11 20:30:59
AppLovin: Q4 Financial Highlights
101 finance2026-02-11 21:30:35
BridgeBio Reports Positive Phase 3 Topline Results for Oral Infigratinib with the First Statistically Significant Improvements in Body Proportionality in Achondroplasia
Finviz2026-02-12 12:36:09
Palo Alto plans dual listing in Tel Aviv after closing $25 billion CyberArk deal
101 finance2026-02-12 15:03:33
Datadog Inc.'s (DDOG) Strong Q4 Reinforces AI Observability Position Amid Competition
Finviz2026-02-12 15:39:39
Cybersecurity Stock in the Spotlight Ahead of Earnings
Finviz2026-02-12 20:39:31
Palo Alto Networks (PANW) Falls More Steeply Than Broader Market: What Investors Need to Know
Finviz2026-02-12 23:48:06
JPMorgan Flags 'AI-Resilient' Software Names After Selloff
Finviz2026-02-13 12:27:43
Alto Neuroscience (stock code: ANRO) has successfully completed patient enrollment for its Phase II proof-of-concept study of the candidate drug Alto-101 for cognitive impairment associated with schizophrenia.
老虎证券2026-02-13 13:28:26
Broadcom Inc. (AVGO) Draws ARK Investment Amid Positive AI Growth Outlook
Finviz2026-02-13 15:12:48
Palo Alto Networks to Report Q2 Earnings: How to Play the Stock
Finviz2026-02-13 16:36:37
Stocks End Modestly Up as Bond Yields Decline
101 finance2026-02-14 00:48:13
Previewing Retail Sector Earnings: A Closer Look
Finviz2026-02-14 00:51:38
Goldman Sachs launches "AI-Resistant" U.S. Stock Investment Portfolio
美股投资网2026-02-14 02:41:03
Cybersecurity Demand Is High-Yet This ETF Is on Sale
Finviz2026-02-14 14:03:42
CrowdStrike (CRWD) Draws Fresh Optimism as HSBC Sees Attractive Entry Point
Finviz2026-02-14 14:24:08
From warnings of a "slippery slope" to describing it as an "existential threat," automotive industry leaders are raising concerns about competition from China
101 finance2026-02-14 15:33:13
What’s Ahead in the Markets This Week: Walmart Reports; Updates on Inflation, Housing, and Trade; Fourth Quarter GDP; and Presidents Day Observance
101 finance2026-02-15 11:03:39
Walmart's financial results, consumer spending trends, and further AI developments: Key highlights to follow this week
101 finance2026-02-15 13:00:40
ANRO stock chart
ANRO stock detailsANRO stock price change
On the last trading day, ANRO stock closed at 16.89 USD, with a price change of 2.74% for the day.
Trade stock futuresAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more